DNMT1 Polyclonal Antibody


  • Specification
  • Target Information
  • Related Products
Cat.No.:  EAb-0499
Product Name:  DNMT1 Polyclonal Antibody
Antibody Type:  Polyclonal
Immunogen:  The immunogen recognized by this antibody maps to a region between residue 700 and 750 of human DNA-Methyltranserase 1 using the numbering given in entry NP_001370.1 (GeneID 1786).
Host:  Rabbit
Isotype:  IgG
Antibody Target:  DNMT1
Purification:  Immunogen affinity purified
Appearance:  Liquid
Formulation:  Tris-Citrate/Phosphate (pH 7.0 - 8.0)
Applications:  WB, IP
Recommended Dilutions/Conditions:  Western Blot; Immunoprecipitation 1:10-1:500
Recommended dilutions/conditions may not be available for all applications. Specific conditions for reactivity should be optimized by the end user.
Species Reactivity:  Human, Mouse
Storage:  -20°C
Storage Buffer:  0.09% Sodium Azide
Warning:  For Research Use Only! Not For Use in Humans.
Accession:  P26358
Alternative Name:  AIM; CXXC9; CXXC9CXXC finger protein 9; CXXC-type zinc finger protein 9; DNA (cytosine-5-)-methyltransferase 1; DNA (cytosine-5)-methyltransferase 1; DNA methyltransferase 1; DNA methyltransferase HsaI; DNA MTase HsaI; DNMT; DNMT1; EC 2.1.1.37; FLJ16293; m.HsaI; MCMT; MCMTMGC104992
Scientific Background:  Inactivation of tumor suppressor genes is a key component of the development of all common forms of human cancers. Aberrant methylation may contribute to many of the changes, both physiological and pathological, associated with aging, including tumor development. Hypermethylation of CpG island-containing promoters is associated with the inactivation of genes important to tumor angiogenesis and progression. DNA methytransferase (DNMT1) is necessary for the maintenance of the methylation process.

Online Inquiry

For Research Use Only. Not for use in diagnostic or therapeutic procedures.

USA

Enter your email here to subscribe.

Follow us on

Easy access to products and services you need from our library via powerful searching tools

Copyright © Creative BioMart. All Rights Reserved.